Publications
Journal Article (17)
1.
Journal Article
9, 97 (2017)
The influence of dopamine-beta-hydroxylase and catechol O-methyltransferase gene polymorphism on the efficacy of insulin detemir therapy in patients with type 2 diabetes mellitus. Diabetology & Metabolic Syndrome 2.
Journal Article
20 (11), pp. 1569 - 1579 (2017)
Alpha-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B. Nature Neuroscience 3.
Journal Article
7, 13713 (2017)
Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson's disease. Scientific Reports 4.
Journal Article
32 (9), pp. 1331 - 1333 (2017)
Neuromelanin magnetic resonance imaging of the Substantia Nigra in LRRK2-related Parkinson's disease. Movement Disorders 5.
Journal Article
295, pp. 77 - 87 (2017)
Nrf2 activation by tauroursodeoxycholic acid in experimental models of Parkinson's disease. Experimental Neurology 6.
Journal Article
56, pp. 7 - 16 (2017)
Sirtuin 2 enhances dopaminergic differentiation via the AKT/GSK-3β/β-catenin pathway. Neurobiology of Aging 7.
Journal Article
73 (4), pp. 459 - 467 (2017)
IGF-I gene therapy in aging rats modulates hippocampal genes relevant to memory function. Journals of Gerontology: Series A, Biological Sciences and Medical Sciences 8.
Journal Article
26 (12), pp. 2231 - 2246 (2017)
Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage. Human Molecular Genetics 9.
Journal Article
114 (25), pp. E4971 - E4977 (2017)
Treatment with diphenyl-pyrazole compound anle138b/c reveals that alpha-synuclein protects melanoma cells from autophagic cell death. Proceedings of the National Academy of Sciences of the United States of America 10.
Journal Article
114 (25), pp. E4971 - E4977 (2017)
Treatment with diphenyl–pyrazole compound anle138b/c reveals that α-synuclein protects melanoma cells from autophagic cell death. Proceedings of the National Academy of Sciences of the United States of America 11.
Journal Article
140, pp. 1399 - 1419 (2017)
Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies. Brain 12.
Journal Article
140, pp. 878 - 886 (2017)
The yin and yang of α-synuclein-associated epigenetics in Parkinson's disease. Brain 13.
Journal Article
15 (3), e1002601 (2017)
The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease. PLoS Biology 14.
Journal Article
7, 42942 (2017)
Alpha-synuclein prevents the formation of spherical mitochondria and apoptosis under oxidative stress. Scientific Reports 15.
Journal Article
26 (19), pp. 3763 - 3775 (2017)
Protein phosphatase 1 regulates huntingtin exon 1 aggregation and toxicity. Human Molecular Genetics 16.
Journal Article
37, pp. 121 - 131 (2017)
Cellular uptake of α-Synuclein oligomer-selective antibodies is enhanced by the extracellular presence of α-Synuclein and mediated via Fcγ receptors. Cellular and Molecular Neurobiology 17.
Journal Article
40, pp. 168 - 181 (2017)
Cell reprogramming: Therapeutic potential and the promise of rejuvenation for the aging brain. Ageing Research Reviews Book Chapter (1)
18.
Book Chapter
Epigenetics in Parkinson's disease. In: Neuroepigenomics in aging and disease (Ed. Delgado Morales, R.) (2017)